Second, while we verified that ATM-MT bladder cancer cells are likely to downregulate the activity of the insulin-like growth factor receptor pathway by upregulating AGE1 gene expression, the functional pathway analysis of ATM mutations needs to be further verified in vitro and in vivo. This evidence concerns the gene ATM and urinary bladder carcinoma.